EyePoint (EYPT) Prepaid Assets (2011 - 2026)
EyePoint (EYPT) posted Prepaid Assets of $1.3 million for Q1 2026, down 63.73% sequentially from $3.5 million in Q4 2025, and down 79.5% YoY from $6.2 million in Q1 2025.
EyePoint (EYPT) Prepaid Assets (2011 - 2026) Analysis & Trends
EyePoint has reported Prepaid Assets for 16 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Prepaid Assets fell 79.5% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 79.5% YoY) and the FY2025 annual result came in at $3.5 million, up 50.28% from the prior year.
- Prepaid Assets slipped to $1.3 million in Q1 2026 per EYPT's latest filing, from $3.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $11.1 million in Q1 2024 and troughed at $782000.0 in Q4 2022.
- A 5-year average of $5.4 million and a median of $5.9 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets plunged 81.46% in 2022, then jumped 364.83% in 2024.
- Over 5 years, Prepaid Assets stood at $782000.0 in 2022, then jumped by 116.75% to $1.7 million in 2023, then surged by 37.99% to $2.3 million in 2024, then surged by 50.28% to $3.5 million in 2025, then plunged by 63.73% to $1.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.3 million, $3.5 million, and $899000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.38 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 3.52 Mn |
| Sep 30, 2025 | 899,000.00 |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 6.22 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 9.64 Mn |
| Mar 31, 2024 | 11.09 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 9.08 Mn |
| Dec 31, 2022 | 782,000.00 |
| Sep 30, 2022 | 10.44 Mn |
| Jun 30, 2022 | 8.85 Mn |
| Mar 31, 2022 | 5.92 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | 3.89 Mn |